Disclosures for "A Review of End-of-Life Discussions and Palliative Care: Implications for Neurological Intensive Care in Latin America and the Caribbean"
-
The institution of Dr. Diaz has received research support from Alzheimer's Association. The institution of Dr. Diaz has received research support from American Academy of Neurology. The institution of Dr. Diaz has received research support from Merck. The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund.
-
The institution of Miss Guarena has received research support from National Science Foundation and Arizona Alzheimer's Consortium.
-
Dr. Garcia has nothing to disclose.
-
Dr. Alarcon-Ruiz has received research support from Universidad CientÃfica del Sur.
-
Mrs. Seal has nothing to disclose.
-
Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qualtrics Inc. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity Pharmaceuticals. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Epilepsy Society . Dr. Rubinos has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Marinus Pharmaceutical. Dr. Rubinos has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for American Epilepsy Society . The institution of Dr. Rubinos has received research support from University of North Carolina .
-
Dr. CRUZ-OLIVER has nothing to disclose.
-
Dr. Carhuapoma has nothing to disclose.